Stay updated on Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial
Sign up to get notified when there's something new on the Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial page.

Latest updates to the Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of 'Colorectal Cancer Metastatic' and 'COLO-007', while significant details regarding a phase 1/2 study of nab-sirolimus in combination with mFOLFOX6 and Bevacizumab have been removed.SummaryDifference38%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial page.